Investors Research Corp’s Editas Medicine EDIT Stock Holding History

Investors Research Corp’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-75	Closed	-$760	–	1048
2023 Q4	$760	Hold	75	–	–	﹤0.01%	1003
2023 Q3	$585	Sell	75 -125	-63%	-$1.07K	﹤0.01%	1023
2023 Q2	$1.65K	Buy	200 +75	+60%	+$653	﹤0.01%	978
2023 Q1	$906	Hold	125	–	–	﹤0.01%	1048
2022 Q4	$1.11K	Hold	125	–	–	﹤0.01%	1040
2022 Q3	$2K	Buy	125 +50	+67%	+$779	﹤0.01%	966
2022 Q2	$1K	Hold	75	–	–	﹤0.01%	1019
2022 Q1	$1K	Hold	75	–	–	﹤0.01%	965
2021 Q4	$2K	Hold	75	–	–	﹤0.01%	907
2021 Q3	$3K	Hold	75	–	–	﹤0.01%	898
2021 Q2	$4K	Hold	75	–	–	﹤0.01%	866
2021 Q1	$3K	Hold	75	–	–	﹤0.01%	870
2020 Q4	$5K	Hold	75	–	–	﹤0.01%	924
2020 Q3	$2K	Buy	+75	New	+$2.44K	﹤0.01%	992

Other funds holding EDIT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Investors Research Corp's EDIT Position: Q1 2024 in Review

Investors Research Corp sold out of Editas Medicine (EDIT) in Q1 2024, closing a stake of 75 shares — an estimated $760 sold.

Investors Research Corp first reported a position in EDIT in Q3 2020 and held it in 14 quarters. The position peaked at $5K in Q4 2020. 225 funds tracked by Wall St. Rank hold EDIT as of Q1 2024.

Investors Research Corp reported no remaining Editas Medicine position as of Q1 2024 after selling out during the quarter.
Investors Research Corp sold 75 Editas Medicine shares in Q1 2024, an estimated $760.
Investors Research Corp first reported a position in Editas Medicine in Q3 2020 and held it in 14 quarters.
Investors Research Corp's Editas Medicine position peaked at $5K in Q4 2020.
225 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2024.

Based on Investors Research Corp's 13F filing for Q1 2024, filed 6 May 2024.